Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) Net Margin (2017 - 2026)

Inspire Medical Systems' Net Margin history spans 10 years, with the latest figure at 5.52% for Q1 2026.

  • On a quarterly basis, Net Margin fell 701.0% to 5.52% in Q1 2026 year-over-year; TTM through Mar 2026 was 14.32%, a 641.0% increase, with the full-year FY2025 number at 15.95%, up 928.0% from a year prior.
  • Net Margin hit 5.52% in Q1 2026 for Inspire Medical Systems, down from 50.56% in the prior quarter.
  • Over the last five years, Net Margin for INSP hit a ceiling of 50.56% in Q4 2025 and a floor of 24.06% in Q1 2022.
  • Historically, Net Margin has averaged 0.06% across 5 years, with a median of 1.65% in 2025.
  • Biggest five-year swings in Net Margin: skyrocketed 3587bps in 2025 and later tumbled -701bps in 2026.
  • Tracing INSP's Net Margin over 5 years: stood at 2.28% in 2022, then surged by 236bps to 7.67% in 2023, then skyrocketed by 92bps to 14.69% in 2024, then soared by 244bps to 50.56% in 2025, then crashed by -111bps to 5.52% in 2026.
  • Business Quant data shows Net Margin for INSP at 5.52% in Q1 2026, 50.56% in Q4 2025, and 4.42% in Q3 2025.